Hanmi Pharmaceutical has consolidated its position as one of the leading drug makers in Korea, standing as the country's top pharmaceutical firm by market cap. However, growing risks from canceled license-out deals have overshadowed its pharmaceutical business recently, putting the group's leadership to the test.